Quotes Synovics Pharmaceuticals, Inc.

Stocks

SYVC

US87163M1018

Pharmaceuticals

Market Closed - 11:31:20 09/06/26 pm AEST 5-day change 1st Jan Change
0.000100 USD +9,900.00% Intraday chart for Synovics Pharmaceuticals, Inc. -.--% -
6 months+9,900.00%
5 years-50.00%

Stock exchange

Performance

1 day+9,900.00%
6 months+9,900.00%
5 years-50.00%
10 years-97.62%

Volumes

markets
Daily volume
14,929
Estimated daily volume
14,929
Record volume 1
551,560
Record volume 2
485,140
Record volume 3
332,060
Capital turnover ratio
0
Float rotation
0

Basic data

Market Cap (USD)
3,648
Net sales ()
25,959,579
Number of employees
155
Sales / Employee (USD)
167,481
Free-Float
95.75%
Free-Float capitalization (USD)
2,982

Indicators

Moving average 100 days
0.0001
Price spread / (MMA100)
-.--%
RSI 9 days
68.27
RSI 14 days
67.6

Change 5-day change 1-year change 3-year change Capi.($)
+9,900.00%-.--%-.--%-.--% 3.65K
+1.26%+6.61%+41.12%+135.59% 1,286B
+0.79%+3.45%+46.35%+93.56% 688B
+0.20%+1.28%+27.01%+112.80% 521B
-0.44%+3.69%+39.60%+69.51% 386B
+0.55%+0.70%+59.00%+44.20% 364B
-0.12%+0.74%+26.78%+58.43% 302B
+0.37%+0.37%+3.62%+36.44% 287B
-0.30%+1.14%+38.59%+74.61% 252B
+0.08%+0.71%+34.25%+124.32% 208B
Average +990.24%+1.87%+31.63%+74.94% 429B
Weighted average by Cap. +0.54%+3.26%+37.63%+96.23%

Historical Quotes: Synovics Pharmaceuticals, Inc.

DateOpeningHighLowCloseVolumeChange
Chart Synovics Pharmaceuticals, Inc.

Price Extremes

Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
10 years 0
Extreme 1.0E-6
0

Monthly variations

Annual variations

2026-.--%
2025+9,900.00%
2024-99.00%
2023+9,900.00%
2022-98.73%
2021+7,800.00%
2020-99.00%
2019-.--%
2018+9,900.00%
2017-99.98%
2014+5.00%
2013+90.48%
2012-81.74%
2011+130.00%
2010-96.67%
2009-34.78%
2008-48.31%
2007-73.98%
2006-22.27%
2005+109.52%
2004+10,400.00%
2003-95.00%
2002-93.85%
2001+30.00%
2000-74.19%
1999+29.17%
1998-80.49%
1997-20.13%
1996+3,750.00%
1995-75.00%
  1. Stock Market
  2. Stocks
  3. SYVC Stock
  4. Quotes Synovics Pharmaceuticals, Inc.